Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Shapiro

Showing results (171-180 of 258) with videos related to

Pageof 26
Sort By:
Research Square|February 3, 2021
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody NeutralizationPengfei Wang, Lihong Liu, Sho Iketani, et al.
Cell Reports|November 25, 2020
Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization EscapeCathrine Scheepers, Valerie Bekker, Colin Anthony, et al.
Vaccines|November 26, 2025
Yeast Display Reveals Plentiful Mutations That Improve Fusion Peptide Vaccine-Elicited Antibodies Beyond 59% HIV-1 Neutralization BreadthCamila T França, Sergei Pletnev, Bharat Madan, et al.
Cell Reports|April 9, 2020
Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex RecognitionJason Gorman, Gwo-Yu Chuang, Yen-Ting Lai, et al.
Science Translational Medicine|June 3, 2026
Neutralizing antibodies elicited in nonhuman primates by an enterovirus D68 virus-like particle vaccine target receptor binding sitesDaniel L Moss, Jiaxuan Cheng, Peter W Krug, et al.
Immunity|January 16, 2021
Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadthXuejun Chen, Tongqing Zhou, Stephen D Schmidt, et al.
Nature Chemical Biology|November 21, 2022
A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPinsVikas Chonira, Young D Kwon, Jason Gorman, et al.
Scientific Reports|January 18, 2026
Genetic diversity in the Plasmodium falciparum next-generation blood stage vaccine candidate antigen PfCyRPA in SenegalAboubacar Ba, Laty Gaye Thiam, Mariama Nicole Pouye, et al.
Elife|May 30, 2018
Routine single particle CryoEM sample and grid characterization by tomographyAlex J Noble, Venkata P Dandey, Hui Wei, et al.
Cell Host & Microbe|March 31, 2021
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersiteGabriele Cerutti, Yicheng Guo, Tongqing Zhou, et al.
Pageof 26

Showing results (171-180 of 258) with videos related to

Sort By:
Pageof 26
Research Square|February 3, 2021
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody NeutralizationPengfei Wang, Lihong Liu, Sho Iketani, et al.
Cell Reports|November 25, 2020
Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization EscapeCathrine Scheepers, Valerie Bekker, Colin Anthony, et al.
Vaccines|November 26, 2025
Yeast Display Reveals Plentiful Mutations That Improve Fusion Peptide Vaccine-Elicited Antibodies Beyond 59% HIV-1 Neutralization BreadthCamila T França, Sergei Pletnev, Bharat Madan, et al.
Cell Reports|April 9, 2020
Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex RecognitionJason Gorman, Gwo-Yu Chuang, Yen-Ting Lai, et al.
Science Translational Medicine|June 3, 2026
Neutralizing antibodies elicited in nonhuman primates by an enterovirus D68 virus-like particle vaccine target receptor binding sitesDaniel L Moss, Jiaxuan Cheng, Peter W Krug, et al.
Immunity|January 16, 2021
Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadthXuejun Chen, Tongqing Zhou, Stephen D Schmidt, et al.
Nature Chemical Biology|November 21, 2022
A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPinsVikas Chonira, Young D Kwon, Jason Gorman, et al.
Scientific Reports|January 18, 2026
Genetic diversity in the Plasmodium falciparum next-generation blood stage vaccine candidate antigen PfCyRPA in SenegalAboubacar Ba, Laty Gaye Thiam, Mariama Nicole Pouye, et al.
Elife|May 30, 2018
Routine single particle CryoEM sample and grid characterization by tomographyAlex J Noble, Venkata P Dandey, Hui Wei, et al.
Cell Host & Microbe|March 31, 2021
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersiteGabriele Cerutti, Yicheng Guo, Tongqing Zhou, et al.
Pageof 26